CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Ketamine 0.3 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04698772
NCT04698772N/ACompleted
CompareCT.gov

Patient Satisfaction With Subdissociative Dose Ketamine Versus Morphine for Emergency Department Pain Control

CHRISTUS Health·observational·Posted Jan 7, 2021·Updated Jan 7, 2021

In Brief

An observational study evaluating Ketamine and Morphine for Abdominal Pain. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The proposed research will be a single blinded (patient) randomized controlled prospective trial of adult patients receiving treatment for moderate to severe abdominal pain to test the hypothesis that patient satisfaction with pain control with Ketamine will be comparable to patient satisfaction with pain control using morphine when treating abdominal pain.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 7, 2021
Enrollment StartDec 19, 2019
Primary CompletionNov 16, 2020
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.5 years ago

Interventions

Ketaminedrug

Blinded study group will receive ketamine for pain control (0.3 mg/kg IV over 3-5 minutes)

Morphinedrug

Blinded study group will receive morphine 4 mg IV push over 3-5 minutes for pain control